In this prospective clinical study, we investigate the baseline expression of HER3 in newly diagnosed breast cancer, as well as the expression of other EGF family proteins and proteins in the PI3K pathway, by breast cancer subtype. This evidence concerns the gene EGF and breast carcinoma.